Genes don’t cause cancer, but genetic mutations can. Our cells have about 22,000 genes, which consist of DNA packed into chromosomes inside the cell nucleus. These genes control a wide range of functions, including cell growth and division. When the genes misbehave or mutate, cancer can develop.
In celebration of Living Proof week, Insight honors cancer survivors with daily posts about survivorship. When I was discharged from the hospital in 1996 after undergoing a stem cell transplant to treat leukemia, I was terrified. Yes, I’d survived cancer treatment, but now I had to deal with something even scarier: the unknown. If you’ve recently ended active treatment and are entering the world of survivorship, here are some tips to keep in mind. It’s OK to feel isolated at first. The end of cancer treatment can bring negative emotions, particularly when those around you think you should be “getting back to normal.” Leaving the safety …
In celebration of Living Proof week, Insight honors cancer survivors with daily posts about survivorship. In 2008 I discovered that my breast cancer, in remission for several years, had spread to my bones. I had just turned 50 and made a list of things I wanted to try that year: ride a helicopter, taste sake, attend a political rally. Going back into cancer treatment was not on the list. My oncologist in Virginia suggested a consult with Eric Winer, MD, director of the Breast Oncology Center in the Susan F. Smith Center for Women’s Cancers. After meeting with him I began traveling to Dana-Farber every …
In celebration of Living Proof week, Insight honors cancer survivors with daily posts about survivorship. The United States today is home to an estimated 12 million cancer survivors, thanks largely to advances in cancer treatment. But the end of treatment is not the end of the cancer experience. For many cancer survivors and caregivers, the years after cancer treatment can bring physical and psychological challenges, says Ann Partridge, MD, MPH, founder and director of Dana-Farber’s Program for Young Women with Breast Cancer and director of the Adult Survivorship Program.
Musician Sheryl Crow announced on June 5 that she has a benign brain tumor known as a meningioma. Below, doctors from Dana-Farber’s Center for Neuro-Oncology describe this condition. The singer-songwriter, a breast cancer survivor, visited Dana-Farber in 2006. Meningiomas are tumors on the surface of the brain, spinal cord, and fluid spaces. They are the most common type of brain tumor, with approximately 55,000 new cases diagnosed annually in the United States.
When Good Morning America host Robin Roberts revealed that she has myelodysplastic syndrome (MDS), she turned a spotlight on a group of blood disorders that affect an estimated 35,000 to 55,000 people in the United States. In patients with MDS, the bone marrow fails to produce normal quantities of blood cells and the cells themselves are often abnormal, resulting in anemia and an array of symptoms including paleness, fatigue, susceptibility to infections, and easy bruising or bleeding. The syndrome, of which there are at least 15,000 new diagnoses each year in the United States, formerly was known as “pre-leukemia” because about …
Inflammatory breast cancer (IBC) is a rare but aggressive form of breast cancer that affects young women more than older women. Because it’s relatively uncommon — it represents less than five percent of all breast cancer cases — people are often confused about what inflammatory breast cancer is and how you can detect it. As a breast oncologist specializing in inflammatory breast cancer, I want to share some of the common myths to help you separate fact from fiction about IBC.
“I don’t believe that optimism can cure cancer, but I do believe one’s general health around the edges can make a difference.” Sam Donaldson, ABC News contributor, learned he had melanoma (a type of skin cancer) in 1997. Despite his diagnosis, he opted to stay positive and learn all he could about his disease. Now chairman of the foundation board at the National Comprehensive Cancer Network (NCCN), Donaldson also works with other cancer research on survivorship initiatives. He talked to us about what he learned, and shares some of his insights here.
More than 600,000 people in the United States are living with a primary brain tumor — one that begins and stays in the brain — and over 60,000 adults and children will be diagnosed with a brain tumor this year. In recognition of May as Brain Tumor Awareness Month, we asked David Reardon, MD, clinical director of the Center for Neuro-Oncology at Dana-Farber/Brigham and Women’s Cancer Center, for the latest advances in brain tumor research and patient care.
Watch and wait. That’s often one of the new terms added to your vocabulary when you’re diagnosed with cancer. Or maybe it’s wait and watch. Or active monitoring. Whatever it’s called, sometimes it’s the term used when there’s nothing to do to treat your particular cancer but wait. That’s a hard thing to do, most doctors will tell you. The natural reaction to a cancer diagnosis is a desire to do something, anything. Melt it. Burn it. Radiate it. Drug it. Remove it. Attack it. Just get the cancer out of you.